COMMUNIQUÉS West-GlobeNewswire
-
L'association TALVEY®▼ (talquetamab) et DARZALEX® (daratumumab) en sous-cutané (SC) montre des réponses profondes et durables chez les patients atteints d'un myélome multiple récidivant ou réfractaire
01/10/2024 - 15:17 -
Positron Corporation Launches Prime Rental Program for Pet-Ct Systems
01/10/2024 - 15:15 -
PacBio, A*STAR, and Macrogen Unveil State-of-the-Art Lab to Accelerate Genomics Innovation in Singapore
01/10/2024 - 15:05 -
Verana Health Announces Launch of Qdata® BPH
01/10/2024 - 15:00 -
GLUCOTRACK ANNOUNCES ORAL & POSTER PRESENTATIONS AT THE 2024 DIABETES TECHNOLOGY MEETING
01/10/2024 - 15:00 -
Biomea Announces Formation of Global Scientific Advisory Board with 22 World-Renowned Diabetes Experts
01/10/2024 - 15:00 -
Bioventus Announces Divestiture of its Advanced Rehabilitation Business to Accelmed Partners
01/10/2024 - 15:00 -
Guardion Health Sciences Announces Adoption of Plan of Dissolution and Liquidation; Appointment of Interim President and CEO
01/10/2024 - 15:00 -
Achieve Life Sciences Strengthens Leadership with Appointment of Dr. Mark Rubinstein, Nicotine Dependence Expert, as New Head of Medical Affairs
01/10/2024 - 14:45 -
Merakris Therapeutics Introduces Dermacyte® AC Matrix: A Lyophilized Amnion Chorion Allograft
01/10/2024 - 14:37 -
Evoke Pharma Announces Proceeds from Existing Warrants and Board Expansion
01/10/2024 - 14:30 -
TerrAscend Closes on Remaining US$26 Million Draw of US$140 Million Debt Financing
01/10/2024 - 14:30 -
GPS Marine Adopts Intelligent Bio Solutions’ Fingerprint Drug Testing Technology to Boost Workplace Safety in Maritime Services
01/10/2024 - 14:30 -
Teva Announces Launch of the First and Only Generic Version of Sandostatin® LAR Depot (octreotide acetate for injectable suspension), in the U.S.
01/10/2024 - 14:29 -
AMN Healthcare Announces CFO Transition
01/10/2024 - 14:15 -
Catalyst Pharmaceuticals to Participate in the BofA Securities CNS Therapeutics Virtual Conference 2024
01/10/2024 - 14:03 -
Yalda Olcott, PharmD, Joins Noom as Head of Healthcare and Pharmacy Operations
01/10/2024 - 14:02 -
Mainz Biomed Publishes CEO Statement; CEO Guido Baechler Eyes Major Growth and U.S. FDA Trials in 2025
01/10/2024 - 14:01 -
Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Publication of New Data Deepening Understanding of Novel Cancer Immunotherapy Treatment Approach Targeting CHI3L1 and its Ability to Inhibit Anti-tumor and Related Tissue Remodeling Responses
01/10/2024 - 14:01
Pages